1.Effects of escitalopram on the expression of glial cell line-derived neurotrophic factor and apoptosis related factors in hippocampus of depression model rats
Chinese Journal of Behavioral Medicine and Brain Science 2013;22(8):688-691
Objective To explore the effects and mechanisms of escitalopram on the expression of glial cell line-derived neurotrophic factor(GDNF) in hippocampus of depression model rats.Methods 40 male SD rats were randomly divided into four groups:control group(group A),control + escitalopram group (group B),depressive group (group C),and depressive + escitalopram group (group D).Chronic mild unpredicted stress (CUMS)with solitary condition was taken to establish rat depression model.And the group B and D were treated with intragastric admistration of escitalopram(10 mg · kg-1 · d-1),the group A and C with sodium chloride.The open-field test and sucrose consumption were used to evaluate the depression behaviors of rats.The apoptotic hippocampal cells were detected by TUNEL.And the expression of GDNF,Bax,Bcl-2 and Caspase3 mRNA were detected by real-time RT-PCR.Results ① Compared with group A(12.0 ± 1.83),the number of apoptotic cells in hippocampus was significantly increased in group C (19.3 ± 1.77) (P < 0.01),while group B (11.9 ± 1.91) was no significant difference (P> 0.05).Compared with group C,the group D(12.7 ± 1.77) had a significant reduction in the number of apoptotic cells (P < 0.01).②Compared with group A,GDNF and Bcl-2 mRNA expression was decreased (P < 0.01),but Bax and Caspase3 mRNA expression was both increased significantly in group C(P<0.01) ;while in group D,GDNF and Bcl-2 mRNA expression was higher (P <0.01),but Bax and Caspase3 mRNA expression was lower than that in group C (P <0.01).Conclusion Escitalopram can improve depressive behaviors and reduce hippocampal apoptosis,which maybe associate with increasing GDNF protein and mRNA expression,and promoting the regeneration of neurons,up-regulating of mRNA Bcl-2 expression,and down-regulating of mRNA Bax and Caspase3 expression.Finally it may prevent the neuronal apoptosis in hippocampal and play the role of cerebral protection.
2.Clinical observation of Shenqi Fuzheng injection combined with chemotherapy for reduction of the side effects of tumor chemotherapy
Fang REN ; Maoyun WANG ; Gege CHEN ; Yixin CUI ; Haiming WANG ; Yu FENG ; Shaodan LI
Cancer Research and Clinic 2018;30(4):251-254
Objective To observe the effect of Shenqi Fuzheng injection combined with chemotherapy on reducing the side effects of malignant tumor chemotherapy. Methods Eighty cancer patients in Traditional Chinese Medicine Hospital of PLA General Hospital from January 2015 to March 2017 were randomly divided into treatment group and control group by using random number table method, each group contained 40 cases. The patients in the treatment group were given Shenqi Fuzheng injection combined with chemotherapy, while the control group used chemotherapy only. Results The incidence of WBC and Plt reduction in the treatment group [35.0 % (14/40), 32.5 % (13/40)] was lower than those in the control group [70.0 % (28/40), 57.5 % (23/40)], and the differences were statistically significant (χ 2= 9.825, P = 0.002;χ2=5.051, P=0.025). The incidence rates of digestive tract reaction and oral ulcers[52.5 %(21/40), 32.5 % (13/40)]were lower than those in the control group[75.0 %(30/40), 60.0 %(24/40)], and the differences were statistically significant (χ2= 4.381, P = 0.036; χ2= 6.084, P = 0.014). The quality of life in the treatment group was significantly improved compared with the control group [(51.4 ±5.1) points vs. (48.3±5.5) points], and the difference was statistically significant(t =2.595,P =0.011). Conclusions Shenqi Fuzheng injection combined with chemotherapy can reduce chemotherapy-induced side effects and improve the life quality of the patients.The injection can be used as the adjuvant therapy for chemotherapy in clinic application.